• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布基纳法索乳腺癌相关基因第11外显子(11.1和11.2)的突变及危险因素

Mutations in exon 11 (11.1 and 11.2) of the gene and risk factors for breast cancer in Burkina Faso.

作者信息

Kiendrebeogo Isabelle Touwendpoulimdé, Zoure Abdou Azaque, Zongo Fabienne Ingrid, Ouattara Abdoul Karim, Ouedraogo Marie N L, Amegnona Jospin, Yonli Albert Théophane, Bayala Bagora, Zongo Nayi, Bambara Aboubacar Hierrhum, Sawadogo Alexis Yobi, Zohoncon Theodora M, Obiri-Yeboah Dorcas, Simpore Jacques

机构信息

Laboratory of Molecular Biology and Genetics (LABIOGENE), UFR/SVT, University Joseph Ki-Zerbo, Ouagadougou, Burkina Faso.

Pietro Annigoni Biomolecular Research Center (CERBA), Ouagadougou, Burkina Faso.

出版信息

J Public Health Afr. 2022 May 25;13(1):1921. doi: 10.4081/jphia.2022.1921. eCollection 2022 May 24.

DOI:10.4081/jphia.2022.1921
PMID:35720803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9202467/
Abstract

Breast cancer is the leading cause of death among women in both developed and developing countries. It is multifactorial, including genetic predispositions such as oncogenic mutations on and 2 genes. The objectives of the present study were to identify oncogenic mutations in exon 11 of the gene and to determine the risk factors for breast cancer among women population in Burkina Faso. This study involved 100 women, including 50 cases of breast cancer and 50 controls (no clinical signs and no family history of breast cancer or other cancers). Mutations in the gene were detected by PCR using sequence primers specific for exon 11 fragments (11.1 and 11.2). In our study population, age (OR=22.40; CI: 4.33-115.82; p<0.001) and obesity (OR=4.23; CI: 1.64-10.92; p=0.003) were risk factors while multiparity was a protective factor for breast cancer (OR=0.35; CI: 0.15-0.81; p=0.02). A mutation was found on both fragments 11.1 and 11.2 of the gene exon 11 in 04/50 (8.0 %) of patients. No mutations were observed in controls. The present study revealed high frequency of oncogenic mutations in exon 11 fragments (11.1 and 11.2) of the gene. These mutations on exon 11 are and involved in the occurrence of breast cancer in our population. Age and obesity were also risk factors for breast cancer among women population in Burkina Faso.

摘要

乳腺癌是发达国家和发展中国家女性死亡的主要原因。它是多因素的,包括遗传易感性,如17号和2号基因上的致癌突变。本研究的目的是鉴定17号基因外显子11中的致癌突变,并确定布基纳法索女性人群中乳腺癌的危险因素。本研究涉及100名女性,包括50例乳腺癌患者和50名对照(无临床症状且无乳腺癌或其他癌症家族史)。使用针对外显子11片段(11.1和11.2)的序列引物通过PCR检测17号基因中的突变。在我们的研究人群中,年龄(OR=22.40;CI:4.33-115.82;p<0.001)和肥胖(OR=4.23;CI:1.64-10.92;p=0.003)是危险因素,而多产是乳腺癌的保护因素(OR=0.35;CI:0.15-0.81;p=0.02)。在50名患者中的4名(8.0%)患者的17号基因外显子11的11.1和11.2片段上均发现了突变。在对照中未观察到突变。本研究揭示了17号基因外显子11片段(11.1和11.2)中致癌突变的高频率。外显子11上的这些突变与我们人群中乳腺癌的发生有关。年龄和肥胖也是布基纳法索女性人群中乳腺癌的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db65/9202467/613da4f3a20d/jpha-13-1-1921-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db65/9202467/8016ddbdd2dd/jpha-13-1-1921-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db65/9202467/613da4f3a20d/jpha-13-1-1921-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db65/9202467/8016ddbdd2dd/jpha-13-1-1921-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db65/9202467/613da4f3a20d/jpha-13-1-1921-g002.jpg

相似文献

1
Mutations in exon 11 (11.1 and 11.2) of the gene and risk factors for breast cancer in Burkina Faso.布基纳法索乳腺癌相关基因第11外显子(11.1和11.2)的突变及危险因素
J Public Health Afr. 2022 May 25;13(1):1921. doi: 10.4081/jphia.2022.1921. eCollection 2022 May 24.
2
BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso.布基纳法索BRCA1基因的c.68_69delAG(外显子2)、c.181T>G(外显子5)、c.798_799delTT和943ins10(外显子11)突变。
J Public Health Afr. 2018 Jul 6;9(1):663. doi: 10.4081/jphia.2018.663. eCollection 2018 May 21.
3
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.印度乳腺癌患者中乳腺癌易感基因BRCA1、BRCA2和p53基因的新型种系突变。
Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8.
4
BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.一般人群中的BRCA1突变与乳腺癌:对35岁之前的女性以及有一级家族史的45岁之前的女性的分析。
JAMA. 1998 Mar 25;279(12):922-9. doi: 10.1001/jama.279.12.922.
5
Identification of BRCA1/2 p.Ser1613Gly, p.Pro871Leu, p.Lys1183Arg, p.Glu1038Gly, p.Ser1140Gly, p.Ala2466Val, p.His2440Arg variants in women under 45 years old with breast nodules suspected of having breast cancer in Burkina Faso.在布基纳法索45岁以下疑似患有乳腺癌的乳腺结节女性中鉴定BRCA1/2基因的p.Ser1613Gly、p.Pro871Leu、p.Lys1183Arg、p.Glu1038Gly、p.Ser1140Gly、p.Ala2466Val、p.His2440Arg变异体。
Biomol Concepts. 2019 Jun 11;10(1):120-127. doi: 10.1515/bmc-2019-0015.
6
Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.种系BRCA1和BRCA2序列改变对印度北部乳腺癌的影响。
BMC Med Genet. 2006 Oct 4;7:75. doi: 10.1186/1471-2350-7-75.
7
Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.中国南方人群散发性乳腺癌中BRCA1基因的突变筛查
Breast. 2008 Dec;17(6):563-7. doi: 10.1016/j.breast.2008.08.003. Epub 2008 Oct 5.
8
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.对具有易感性突变高风险女性的BRCA1基因序列分析。风险因素分析及对基因检测的意义。
JAMA. 1997 Oct 15;278(15):1242-50.
9
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.649例卵巢癌患者群体中胚系BRCA1和BRCA2基因突变的患病率及外显率
Am J Hum Genet. 2001 Mar;68(3):700-10. doi: 10.1086/318787. Epub 2001 Feb 15.
10
[Study of BRCA1 and BRCA2 gene mutations in human sporadic breast cancers].[人类散发性乳腺癌中BRCA1和BRCA2基因突变的研究]
Zhonghua Wai Ke Za Zhi. 2007 Apr 1;45(7):480-2.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Age as a risk factor for breast cancer-related lymphedema: a systematic review.年龄作为乳腺癌相关淋巴水肿的危险因素:一项系统综述。
J Cancer Surviv. 2023 Feb;17(1):246-253. doi: 10.1007/s11764-021-00994-z. Epub 2021 Jan 24.
3
A systematic review of the international prevalence of mutation in breast cancer.
乳腺癌基因突变国际患病率的系统评价。
Clin Epidemiol. 2019 Jul 11;11:543-561. doi: 10.2147/CLEP.S206949. eCollection 2019.
4
Breast cancer: descriptive profile of 80 women attending breast cancer care in the Department of General and Digestive Surgery of CHU-YO.乳腺癌:朱约大学综合与消化外科收治的80例乳腺癌患者的描述性概况
Pan Afr Med J. 2017 Dec 26;28:314. doi: 10.11604/pamj.2017.28.314.10203. eCollection 2017.
5
Multiparity and Breast Cancer Risk Factor among Women in Burkina Faso.布基纳法索女性的多胎生育与乳腺癌风险因素
Asian Pac J Cancer Prev. 2016 Dec 1;17(12):5095-5099. doi: 10.22034/APJCP.2016.17.12.5095.
6
Features of breast cancer in developing countries, examples from North-Africa.发展中国家乳腺癌的特征,以北非为例。
Eur J Cancer. 2014 Jul;50(10):1808-1818. doi: 10.1016/j.ejca.2014.03.016. Epub 2014 Apr 21.
7
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.全面聚焦乳腺癌中BRCA1和BRCA2突变的全球谱系。
Biomed Res Int. 2013;2013:928562. doi: 10.1155/2013/928562. Epub 2013 Nov 7.
8
Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.BRCA1 基因突变筛查在摩洛哥早发性和家族性乳腺癌/卵巢癌中的应用。
Int J Med Sci. 2013;10(1):60-7. doi: 10.7150/ijms.5014. Epub 2012 Dec 10.
9
BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families.苏丹家庭中有已知乳腺癌病例的中学女生的BRCA 1和2基因突变情况。
Int J Health Sci (Qassim). 2012 Jan;6(1):63-71. doi: 10.12816/0005974.
10
High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome.卵巢癌基因组中高水平的染色体畸变与不良的临床结局相关。
Gynecol Oncol. 2013 Mar;128(3):500-5. doi: 10.1016/j.ygyno.2012.11.031. Epub 2012 Nov 28.